Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (998)
Relay Therapeutics, Inc. (RLAY)
SVF Pauling (Cayman) Ltd — 10% Owner
Shares
6,000,000
Price
$19.40
Total Value
$116.40M
Shares Held After
21,904,963
% of Holdings
21.5%
Monopar Therapeutics (MNPR)
Anderson Raymond — Director
Shares
1,802
Price
$113.05
Total Value
$203.72K
Shares Held After
23,751
% of Holdings
7.1%
Monopar Therapeutics (MNPR)
Anderson Raymond — Director
Shares
646
Price
$110.07
Total Value
$71.11K
Shares Held After
25,523
% of Holdings
2.5%
Monopar Therapeutics (MNPR)
Anderson Raymond — Director
Shares
694
Price
$110.04
Total Value
$76.37K
Shares Held After
26,169
% of Holdings
2.6%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
280
Price
$380.00
Total Value
$106.40K
Shares Held After
0
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
3,972
Price
$16.56
Total Value
$65.78K
Shares Held After
138,471
% of Holdings
2.8%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
14,036
Price
$2.21
Total Value
$30.97K
Shares Held After
2,230,052
% of Holdings
0.6%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
9,845
Price
$16.56
Total Value
$163.03K
Shares Held After
343,259
% of Holdings
2.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
5,870
Price
$126.06
Total Value
$739.97K
Shares Held After
9,755
% of Holdings
37.6%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
25,085
Price
$125.47
Total Value
$3.15M
Shares Held After
15,625
% of Holdings
61.6%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
2,798
Price
$16.56
Total Value
$46.33K
Shares Held After
127,771
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
16,201
Price
$51.06
Total Value
$827.18K
Shares Held After
195,862
% of Holdings
7.6%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
20,799
Price
$50.31
Total Value
$1.05M
Shares Held After
212,063
% of Holdings
8.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
18,921
Price
$49.57
Total Value
$937.96K
Shares Held After
467,187
% of Holdings
3.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
26,522
Price
$7.54
Total Value
$199.98K
Shares Held After
4,332,917
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
26,522
Price
$7.54
Total Value
$199.98K
Shares Held After
4,332,917
% of Holdings
0.6%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
8,796
Price
$83.12
Total Value
$731.09K
Shares Held After
54,324
% of Holdings
13.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$520.50
Total Value
$41.64K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
668
Price
$519.91
Total Value
$347.30K
Shares Held After
324,523
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,387
Price
$518.80
Total Value
$1.24M
Shares Held After
325,191
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,004
Price
$518.08
Total Value
$1.04M
Shares Held After
327,578
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,332
Price
$516.95
Total Value
$1.21M
Shares Held After
329,582
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,029
Price
$516.12
Total Value
$1.05M
Shares Held After
331,914
% of Holdings
0.6%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
43
Price
$36.52
Total Value
$1.57K
Shares Held After
55,285
% of Holdings
0.1%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.38
Total Value
$138.00K
Shares Held After
316,142
% of Holdings
31.6%
PRECIGEN, INC. (PGEN)
Tennant Phil — Chief Commercial Officer
Shares
79,166
Price
$7.50
Total Value
$593.75K
Shares Held After
141,992
% of Holdings
35.8%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
15,342
Price
$7.50
Total Value
$115.06K
Shares Held After
468,865
% of Holdings
3.2%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
13,160
Price
$50.00
Total Value
$657.98K
Shares Held After
232,862
% of Holdings
5.3%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
21,623
Price
$7.34
Total Value
$158.71K
Shares Held After
4,359,439
% of Holdings
0.5%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
21,623
Price
$7.34
Total Value
$158.71K
Shares Held After
4,359,439
% of Holdings
0.5%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
300
Price
$82.53
Total Value
$24.76K
Shares Held After
54,324
% of Holdings
0.5%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
3,296
Price
$10.78
Total Value
$35.53K
Shares Held After
318,326
% of Holdings
1.0%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
21,649
Price
$10.77
Total Value
$233.16K
Shares Held After
2,525,429
% of Holdings
0.8%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
3,035
Price
$10.77
Total Value
$32.69K
Shares Held After
264,378
% of Holdings
1.1%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
1,897
Price
$10.78
Total Value
$20.45K
Shares Held After
326,898
% of Holdings
0.6%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
10
Price
$4.50
Total Value
$45.00
Shares Held After
2,433,270
% of Holdings
0.0%
Adlai Nortye Group Ltd. (ANL)
Ye Xiaofeng — CFO
Shares
6,000
Price
$13.98
Total Value
$83.88K
Shares Held After
153,424
% of Holdings
3.8%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
1,794
Price
$1.33
Total Value
$2.39K
Shares Held After
601,911
% of Holdings
0.3%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
906
Price
$19.10
Total Value
$17.30K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,305
Price
$513.35
Total Value
$669.92K
Shares Held After
324,443
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,592
Price
$512.46
Total Value
$1.84M
Shares Held After
325,748
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,056
Price
$511.63
Total Value
$1.56M
Shares Held After
329,340
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,323
Price
$510.52
Total Value
$675.42K
Shares Held After
332,396
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
224
Price
$509.41
Total Value
$114.11K
Shares Held After
333,719
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
330
Price
$6.98
Total Value
$2.30K
Shares Held After
51,851
% of Holdings
0.6%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
125,000
Price
$26.91
Total Value
$3.36M
Shares Held After
69,302
% of Holdings
64.3%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
107,374
Price
$1.75
Total Value
$188.36K
Shares Held After
4,853,818
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
53,613
Price
$10.64
Total Value
$570.44K
Shares Held After
1,373,397
% of Holdings
3.9%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
25,000
Price
$65.07
Total Value
$1.63M
Shares Held After
37,025
% of Holdings
40.3%
Kura Oncology, Inc. (KURA)
WILSON TROY EDWARD — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
479,194
% of Holdings
20.9%
Showing 601–650 of 998 transactions (page 13 of 20)